• 1. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 2. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 3. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615

• Solvents and Organic Chemicals Organic Compounds Benzenoids Indanes Indanes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Indanes

Introduction to cis-1-Amino-2,3-dihydro-1H-inden-2-ol (CAS No. 140632-20-8)

cis-1-Amino-2,3-dihydro-1H-inden-2-ol (CAS No. 140632-20-8) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as cis-1-Aminoindan-2-ol, is characterized by its unique structural features and potential biological activities. Its chemical structure consists of an indan framework with an amino group and a hydroxyl group in specific cis configurations, making it a valuable building block for the synthesis of more complex molecules.

The cis configuration of the amino and hydroxyl groups is crucial for the compound's reactivity and biological properties. This configuration allows for specific interactions with biological targets, which can be exploited in the development of novel therapeutic agents. Recent studies have highlighted the importance of cis-1-Aminoindan-2-ol in various medicinal applications, including its potential as a lead compound for drug discovery.

In the context of medicinal chemistry, cis-1-Aminoindan-2-ol has been investigated for its role in modulating enzyme activities and receptor interactions. One notable area of research involves its use as a scaffold for the development of inhibitors targeting specific enzymes involved in disease pathways. For instance, studies have shown that derivatives of cis-1-Aminoindan-2-ol can effectively inhibit certain kinases, which are key players in signal transduction pathways associated with cancer and inflammatory diseases.

Moreover, cis-1-Aminoindan-2-ol has demonstrated promising activity as a ligand for G protein-coupled receptors (GPCRs). GPCRs are a large family of membrane receptors that play critical roles in cellular signaling and are important targets for drug development. Research has indicated that cis-1-Aminoindan-2-ol and its derivatives can modulate the activity of specific GPCRs, potentially leading to new therapeutic strategies for conditions such as cardiovascular diseases and neurological disorders.

The synthetic accessibility of cis-1-Aminoindan-2-ol is another factor contributing to its appeal in pharmaceutical research. Various synthetic routes have been developed to produce this compound efficiently, allowing for the rapid generation of diverse derivatives. These synthetic methods often involve chiral catalysis or asymmetric synthesis techniques to ensure the correct stereochemistry, which is essential for the desired biological activity.

Recent advancements in computational chemistry have also facilitated the study of cis-1-Aminoindan-2-ol. Molecular modeling and docking studies have provided insights into the binding modes and interactions of this compound with its biological targets. These computational tools help predict the activity and selectivity of cis-1-Aminoindan-2-ol derivatives, guiding experimental efforts towards more effective drug candidates.

In addition to its potential as a therapeutic agent, cis-1-Aminoindan-2-ol has been explored for its use in diagnostic applications. Its unique chemical properties make it suitable for labeling and imaging techniques, which can be used to monitor biological processes at the molecular level. For example, derivatives of cis-1-Aminoindan-2-ol have been developed as fluorescent probes for live-cell imaging, providing valuable information on cellular dynamics and disease progression.

The safety profile of cis-1-Aminoindan-2-ol is an important consideration in its development as a pharmaceutical product. Preclinical studies have generally shown favorable safety profiles, with low toxicity and good pharmacokinetic properties. However, ongoing research is necessary to fully understand the long-term effects and potential side effects of this compound and its derivatives.

In conclusion, cis-1-Aminoindan-2-ol (CAS No. 140632-20-8) represents a promising molecule with diverse applications in medicinal chemistry and pharmaceutical research. Its unique structural features, synthetic accessibility, and potential biological activities make it an attractive candidate for further investigation and development. As research continues to advance, it is likely that new insights into the properties and applications of cis-1-Aminoindan-2-ol will emerge, contributing to the discovery of innovative therapeutic solutions.

• 7480-36-6(cis-1-Amino-1,2,3,4-tetrahydronaphthalen-2-ol)
• 74165-73-4(1-Amino-2-indanol)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)